Legal Representation
Attorney
Ashly I. Boesche
USPTO Deadlines
Next Deadline
14 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-08-06)
Due Date
August 06, 2025
Grace Period Ends
February 06, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 27, 2025 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Mar 27, 2025 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Mar 27, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Dec 9, 2024 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Aug 6, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Aug 6, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 21, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 21, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 1, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 15, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 3, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 3, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 3, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 27, 2019 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Mar 14, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 14, 2019 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 14, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 8, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 2, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 13, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, immunoglobulin for the treatment of immune deficiencies and autoimmune diseases
Classification
International Classes
005